- Science
- Global
Engineered nanoparticles could deliver better targeted cancer treatment to lymph nodes
- February 21, 2026 at 10:00 PM
- 10 views
Scientists at McGill University and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver cancer immunotherapy that caused fewer side effects compared to standard treatment in a preclinical study. The work is published in the journal Proceedings of the National Academy of Sciences.
Originally published at Phys.org